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Abstract: 
Frailty is a geriatric syndrome characterized by a of vulnerability status associated with 
declining function of multiple physiologic systems and loss of physiologic reserves. Two main 
models of frailty have been advanced: phenotypic model (primary frailty) or deficits 
accumulation model (secondary frailty), and different instruments have been proposed and 
validated  to measure frailty. However measured, frailty correlates to medical outcomes in the 
elderly, and has been shown to have prognostic value for patients in different clinical settings,  
such as  in patients with coronary artery disease, after cardiac surgery or TAVR, in patients 
with CHF or after LVAD implantation. 
The prevalence, clinical and prognostic relevance of frailty in a Cardiac Rehabilitation (CR) 
setting has not yet been well characterized, despite the increasing frequency of elderly 
patients in CR, where frailty is likely to influence the onset,  type and intensity of the exercise 
training program, therefore leading to design tailored rehabilitative interventions for these 
patients. 
Therefore, we need to start looking for frailty in patients entering CR programs and become 
more familial with some of the most adopted  tools to recognize and evaluate the severity of 
this condition. Furthermore, we need to better understand whether exercise-based CR may 
change the course and the prognosis of frailty in cardiovascular patients. 
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Introduction 
We belong to an aging world where people are living longer. In 2030,  progressive population 
ageing  will lead to an increase in the proportion of people aged over 65  from 17.4 % to 25.6 %, 
and the population of elderly people will almost double from 87.5 million in 2010 to 152.6 million 
in 2060. .
1
 Progressive aging is associated with geriatric syndromes (particularly frailty) that pose a 
severe burden on health systems. Therefore, there is a need to better understand these 
syndromes, with particular attention to the relevance of frailty in the context of care of older 
cardiac patients, including Cardiac Rehabilitation (CR). 
 
Frailty and its relationship with disability and comorbidity  
Frailty is characterized by impairment in many domains (e.g. physical, psychological and social) 
with consequent effects on mortality, hospitalization, dependence, disability and significant 
healthcare cost.
2
 Although varying definitions exist, there is a common thread in that frailty is a 
dynamic age-related vulnerability
3
 characterized by declining function, associated with a loss of 
physiologic reserves of multiple organs or systems, and an increased risk of negative outcomes, 
such as institutionalization and death.
4,5
 The pathophysiologic mechanisms underlying the 
development or progress of a frailty status are multifactorial, and include inflammatory 
mechanisms, the hypothalamic-hypophysary axis, and anabolic-catabolic hormone imbalance.
5
 
Studies show that frailty, independently of how it is measured, is significantly and independently 
correlated to medical outcomes.
6,7
 Despite the relevance of frailty as a prognostic indicator, 
uncertainty remains regarding its definition, its measurement, the feasibility of its measurement in 
clinical practice and whether such measurements can be influenced by interventions or describe 
the progress or deterioration of health status . This is particularly true in the CR setting, where the 
increasing age of patients admitted to CR poses problems in individualizing models of clinical 
evaluation and interventions. 
The extent of frailty is not determined purely by the magnitude and frequency of comorbidity or 
disability, since patients with the same comorbidity or disability may present with different 
degrees of frailty or no frailty at all. On the other hand, a patient may be frail with few 
comorbidities or disabilities.
8
 Based on data from the Cardiovascular Health Study, about 25% of 
older patients show signs of frailty without either multiple comorbidities or disabilities.
9
 Disability 
may be a consequence of frailty but, alternatively, disability may be closely linked to the 
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development or worsening of frailty status; in particular, so called primary frailty, described in 
older patients without overt pathologic conditions, can lead to diseases or disability and to 
secondary frailty that in turn may worsen the phenotypic presentation of frailty.
10
 The recognition 
and measurement of frailty and the possibility of modifying this status are important issues within 
and beyond modern geriatric medicine. 
 
Frailty Models 
Two main models of frailty have been proposed. The phenotype model proposed by Fried et al. 
views frailty as a biological syndrome resulting from cumulative decline across multiple 
physiological systems.
4
 The model advanced by Rockwood et al. views frailty as a multidimensional 
risk state that can be measured more by the quantity than by the nature of health problems.
11-13
 
 
Primary frailty model-The Phenotype model. According to Fried et al., a wealth of epidemiologic 
or observational studies have described the presence of frailty in the general elderly population 
(Physiologic aging). In this environment frailty has beĞŶĚĞĨŝŶĞĚĂƐ “WƌŝŵĂƌǇ&ƌĂŝůƚǇ ?, a phenotypic 
presentation involving decline in physical functioning and psychological status, without taking into 
consideration associated diseases or pathologic conditions. &ƌŝĞĚ ?ƐPhenotype Frailty index4 (PFI) 
has been widely adopted: it was derived from an analysis of five health domains: nutrition, 
physical exhaustion, low energy expenditure (or inactivity status), mobility, and muscular strength 
(Table 1). Deterioration of each of these domains was scored as 1 if present or 0 if absent, giving a 
potential score spanning from 0 to 5. The phenotype model classified three categories: Robust (no 
deterioration), pre-frail (1 or 2 function deterioration), or frail (3 or more function deterioration). 
This categorization was independently correlated with outcomes, such as survival, falls, disability 
and institutionalization.
4
 
 
Secondary Frailty model-Accumulation of deficit model. The conceptualization of frailty proposed 
by Rockwood et al. considers the accumulation of multiple deficits such as symptoms, signs, 
disabilities, pathologic conditions, and abnormal laboratory values (Secondary Frailty).
11-14
 In this 
model, a frailty index (FI) was measured as deficit accumulation (Table 2). Each deficit can be 
coded as binary (1 or 0) or ordinal (0, 0.5, 1). This FI is the sum of the deficit values divided by the 
total number of deficits listed (e.g. 10 deficits present out of 40 gives a FI ratio of 10/40 = 0.25) 
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and is significantly correlated with outcomes: for example, with each unit increase the hazard rate 
for mortality increased by 4%.
15
 
Frailty indices adopting the deficit accumulation model can be derived from different numbers and 
types of variables, provided certain criteria are fulfilled.
14
 The number of deficits, rather than a 
single deficit, is related to adverse outcomes, since the final number reflects a global measure of 
vulnerability. A patient with a score <0.2 would be considered not frail, an increasing score 
indicates an increased level of frailty. In order for a FI to be able to capture sufficient features or 
risk factors for frailty, it should include at least 40 items, covering several health domains, such as 
physical, cognitive, psychological and social.
14
 It is important to note that 1) frailty increase 
parallels aging, independently of baseline frailty, and 2) evaluation of interventions to reduce 
frailty must take into consideration a natural physiological increase in frailty with age. 
 
Frailty Assessment 
Assessing Instruments. An important issue in the clinical environment, and particularly in primary 
care, is that the measurement of frailty based on either the Phenotypic or Deficit accumulation 
model may be complex and time consuming. There are, however, alternative instruments to apply 
in clinical practice for screening and evaluating frailty in the general population (Table 3). Some 
follow the phenotypic model,
16-19
 others consist of administered or self-administered 
questionnaires,
20,21
 and some require clinical evaluation
22
 or task performance and measurement 
such as the Edmonton Frailty Scale (EFS).
23
 Some scales are designed to be screening instruments 
18
 and others to be more multifaceted tools requiring Comprehensive Geriatric Assessment 
(CGA).
24
 They are designed for use with different groups of individuals, and differ in their feasibility 
and prognostic ability.  
Despite these differences, all scales were predictive of all-cause mortality or of relevant elderly 
outcomes, in most cases independently from other prognostic indices. A recent comparison of 
these scales in the SHARE survey
25
 showed some differences in their prognostic predictive ability. 
ROC curves showed that FI derived from the deficit accumulation model, FI derived from CGA (FI-
CGA) and EFS performed slightly better than other scales. 
Since CGA, consisting in a multidimensional assessment of several health domains, is the 
cornerstone of modern geriatric care,
26
 FI-CGA may be considered as one of the best models to 
measure frailty. The FI-CGA, validated in the Canadian Study of Health and Aging (CSHA), a large 
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population-based study,
24-27
 explored ten domains, assigning a score to each domain and 
constructing a frailty categorization: mild (FI-GCA 0 W7), moderate (FI-CGA 7 W13), severe frailty (FI-
CGA >13).
24
 The same data from CGA can be analyzed by counting the deficit according to the 
deficit accumulation model,
3
 and both type of measurements have been correlated to outcome.
27
  
Extensive literature has shown that frailty can indeed be measured with relative ease even in 
hospital settings, for patients in general medical wards,
6,7,28-31
 geriatric units,
32,33
 survivors of ICU 
or Emergency department
34,35 
including critical oncologic
36
 or dialyzed patients
37
 (Table 4). In these 
settings, frailty has been assessed by a variety of tools including the FI-CGA instrument,
28,30
 the  
CSHA Clinical Frailty Scale
6,7,31,34,37 
and the phenotypic model.
29,35,36
 Frailty varied from 20% to 
82%, according to the scale and the population examined. 
A direct comparison among some of these scales in hospitalized patients aged >65 years was 
reported by Pilotto et al., who described an innovative frailty instrument based on a modified CGA 
(CGA-based Multidimensional Prognostic Index -MPI).
38
 The MPI integrated data from eight 
domains such as disability (Basic and instrumental activities of daily life WBADL- IADL), cognitive, 
nutritional, comorbidities, drug use, risk of developing pressure sores, and co-habitation status. 
ROC analysis for the endpoint of mortality showed good performance of MPI compared with FI 
and  FI-CGA .  
 
Value of Frailty instruments in measuring outcome 
Frailty depends on several interrelated factors and can change over time. Since frailty is a dynamic 
process influenced by progressive aging,
39,40
 it is uncertain whether it can be used as an outcome 
measure of an intervention.
41
 Therefore, an evaluative outcome instrument to measure frailty 
with sound clinimetric properties is needed.
9
 A review of many commonly adopted frailty 
instruments in clinical practice has analyzed their clinimetric properties (agreement, construct 
validity, responsiveness, interpretability, content validity, internal consistency, floor and ceiling 
effect).
42
 Frailty instruments have mostly been validated as prognostic tools, but their ability for 
capturing intervention-induced changes in frailty over time is unclear. At the present time, and 
with caution, the FI calculated according to the deficit accumulation model
11,12
 appears, from the 
clinimetric standpoint, the most suitable and reliable to capture changes in frailty over time. Using 
the frailty index as a tool to estimate the increase in healthcare resources required for different 
levels of frailty may help to identify the investment needed to reduce frailty in the community.
43,44 
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Frailty in cardiology 
With progressive population aging, the burden of cardiovascular disease has become prevalent as 
a cause of mortality, morbidity and disability.
45
 Therefore, there has been a recent surge of 
interest in evaluating frailty in patients with cardiovascular conditions. Frailty has been assessed in 
patients affected by various cardiovascular diseases and many of the instruments adopted have 
demonstrated prognostic value;
46-48
 they may have value in defining guidelines for cardiac 
patients ? management during hospitalization and after discharge. Each of the instruments 
proposed has its own grade of complexity and prognostic information. In general, even as a sole 
prognostic indicator and with the above limitations, instruments describing a frailty status in 
several populations of cardiac patients have outscored other more usually adopted prognostic 
indicators .
 46-48
  
 
Frailty in elderly patients with acute coronary syndrome (ACS)PTCA  
Many studies have evaluated frailty in elderly patients after an ACS or PTCA  by using several 
instruments, such as the phenotypic model (PFI),
4
 the CSHA Clinical Frailty Scale,
22
 or the EFS.
23
 In 
this setting frailty ranged from 10% to 48%, and higher levels of frailty were associated with worse 
outcomes (Table 5).
47, 49-54
 
. These studies showed an independent added prognostic value of frailty assessment, and 
although larger studies are needed to refine risk prediction models, it is suggested that clinicians 
and researchers should consider how they can embed frailty measurement into clinical practice.  
 
Frailty in elderly patients undergoing cardiac surgery  
In the current era, the elderly represent the fastest growing group of patients referred for cardiac 
surgery, with the proportion of patients aged 75 years or older rising from 16% in 1990 to 25% in 
most recent estimates.
55
 These complex and often frail patients are at increased risk of falls, 
prolonged hospitalization,  mortality after surgery.
56,57
 For this reason, many groups have 
evaluated preoperative frailty to increase prognostic capability.
55,58,59
  
Recently, Afilalo et al.
55
 in a population of 152 elderly patients (>70 years) undergoing coronary 
artery bypass graft and/or valve surgery, evaluated the incremental prognostic value of four 
different frailty scales and of three disability scales compared with classical cardiac surgery risk 
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scores. Frailty Scales adopted in this study were the Fried frailty scale;
4
 the expanded Fried frailty 
scale (addition of  cognitive impairment and depressed mood);
60
 the 4-item MacArthur Study of 
Successful Aging frailty scale sub-dimensions [gait speed, handgrip strength, inactivity, cognitive 
impairment];
61
 and gait speed alone. Compared with the Parsonnet score
62
 or the Society of 
Thoracic Surgeons Predicted Risk of Mortality or Major Morbidity score (STS-PROMM),
63
 the 
addition of frailty and disability provided independent incremental value and improved model 
discrimination for in-hospital postoperative mortality or major morbidity. Thus, the integration of 
frailty, disability, and risk scores should better characterize elderly patients referred for cardiac 
surgery and identify those who are at increased risk.  
 
Transvalvular aortic valve replacement (TAVR)  
TAVR has shown to be a successful intervention in elderly patients with aortic stenosis, and  
patients after TAVR benefit from CR  despite their older age and clinical complexity and frailty
64
 .  
Several studies have recently described the added prognostic value of frailty evaluation over 
standard criteria in elderly patients undergoing TAVR  
A modified Fried Frailty score (gait speed, grip strength, serum albumin, and activities of daily 
living) in very old patients was independently associated with increased 1-year mortality after 
TAVR. 
65
 A Frailty index based on assessment of cognition, mobility, nutrition, BADL and IADL 
predicted functional decline after TAVR, suggesting that this index might identify elderly patients 
who could potentially benefit from additional geriatric interventions. 
66
 Another study reported 
that a Multidimensional Geriatric Assessment (MGA)-based score (including cognition, nutrition, 
mobility, BADL, plus a  ?home-made ? frailty index) predicted 1 year mortality and major adverse 
cardiovascular and cerebral events (MACCE) after TAVR in patients aged >70 years.
67
 Recently, a  
PARTNER Trial sub-study found that, in older recipients of TAVR, frailty, assessed using a modified 
frailty phenotype model (serum albumin, dominant handgrip strength, gait speed, and activity of 
daily living ), independently predicted all-cause mortality or poor outcome at 1 year.
68
 
A recent review of 6 studies and 4756 patients undergoing cardiac surgery or TAVR concluded that 
frail elderly patients have a higher likelihood of mortality, morbidity, functional decline, and 
MACCE following cardiac surgery or TAVR, regardless of the frailty assessment tool.
69
 
All of the studies
65-69
 have reported frailty measurement before surgery or intervention and 
utilized it as an added prognostic tool for later events, but none of these studies has evaluated 
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frailty in the immediate post-operative period, which is usually unstable and therefore not well 
suited for measurements of frailty that require clinical stability. 
 
Frailty in elderly patients with chronic heart failure /Left ventricular assist device  
Frailty prevalence in chronic heart failure (CHF) patients ranges from 15% to 74%, depending on 
the population and assessment method . The FRAIL-HF study
70
 reported that 70.2% of 
nondependent older patients hospitalized for CHF are frail as evaluated by the Fried criteria. In 
these patients a superimposition of primary frailty associated with progressive aging and frailty 
secondary to CHF is difficult to disentangle, since both share similar physiopathological 
mechanisms, such as anabolic Wcatabolic and neurohormonal imbalance, systemic inflammation, 
increased oxidative stress or mitochondrial dysfunction.
71
 In CHF frailty is consistently associated 
with poor outcome, quality of life, disability or hospitalization.
72-80
  
Mc Nallan et al. reported that frailty, measured by the Fried criteria, was an independent predictor 
of hospitalizations in community patients with CHF.
72
 Cacciatore et al. utilizing the Lachs frailty 
staging score (based on sensorial compromise, cognitive impairment, urinary incontinence, poor 
social support and disability), found that the probability of death in patients with CHF and frailty 
score of 3 was 100% as compared with 55% in patients with CHF and frailty score of 1.
73
 Lupon et 
al. found that a scale based on evaluation of BADL-IADL, cognitive function, psychologic and social 
status,  was independently correlated with quality of life, hospitalization and mortality.
74,75
  
Volpato et al.
76
 and Chiarantini et al.
77
 utilizing the Short Physical performance Battery (SPPB), a 
test measuring lower extremity physical performance by walking speed, balance test and ability to 
stand up from a chair,
78
 found in patients hospitalized for CHF that poor SPPB scores at hospital 
discharge were predictive of a greater risk of rehospitalization or death. Even single items such as  
low gait speed or low grip strength in community living CHF patients were correlated with 
hospitalization at follow up,
79
 and Barthel index of disability and cognitive compromise correlated 
with 6 months mortality in CHF patients admitted to hospital.
80
  
Recently, Dunlay et al found, in a small cohort study of advanced CHF patients undergoing left 
ventricular assist device (LVAD) implantation, that pre-intervention frailty was associated with 
increased mortality.
81
 This suggests that frailty assessment may be relevant for identifying suitable 
candidates for this invasive procedure. There is evidence that LVAD intervention
82
 and heart 
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transplantation
83
 improve some biologic, structural, and functional markers of frailty associated 
with CHF. 
 
Frailty and Cardiac Rehabilitation (CR)  
Despite the negative bias for referring very elderly patients with complex comorbidities and frailty 
to CR,
84
 at present patients older than 75 years represent about one third of those referred to 
CR.
85
 Thus frailty might be present in a substantial proportion of patients admitted to CR, and this 
condition needs specific consideration.  
The prevalence of frailty and its clinical and prognostic relevance has not as yet been well 
characterized in the environment of CR, although many studies have reported measurement of 
frailty in patients with coronary syndromes in ICU or in cardiology wards,
49-52
 and others have 
underscored the close link between frailty and CHF.
71-80
 Since patients after ACS or CHF represent 
a considerable proportion of those participating in CR,
85,86
 we may suggest that frailty 
measurement should be performed in CR, to help plan their management and estimate their 
prognosis. 
Frailty complicates the management of elderly patients, since it may affect the type and timing of 
diagnostic procedures and pharmacologic and non-pharmacologic treatment. Their baseline 
physical function evaluation should be tailored to their physical conditions, and the CR program 
should be individualized on the basis of their functional compromise and disability.
87
 
Pharmacologic treatment should be carefully weighted, balancing guidelines recommendations 
with a prudent approach, since associated comorbidities may increase iatrogenic complications. In 
community living or institutionalized frail elderly patients tailored exercise training has improved 
to some degree their physical function and quality of life.
88-93
 Individuals at higher risk of disability 
at baseline derive the most benefit from these types of interventions
90
 by increasing gait speed, 
improving balance, and performance in activities of daily life,
91
 or SPPB.
92
. However, it is still 
uncertain whether these positive results can be applied to CR patients. Particularly in patients with 
CHF, structured exercise training improves the neurohormonal, inflammatory, and metabolic 
parameters of CHF-related frailty and has favorable effects on physical function, functional 
capacity and quality of life.
70
 It is still uncertain whether therapeutic interventions 
(pharmacological and non-pharmacological) that have proven successful in younger CHF patients 
will be successful in elderly patients, since the majority of randomized clinical trials in CHF do not 
11 
 
include very elderly patients with frailty. However, from a practical standpoint, exercise-based CR 
program should be implemented, with caution, aiming at obtaining improvement in physical 
mobility, functional capacity, fall prevention, disability prevention or decreased progression, and 
improvement in quality of life. 
Nutrition is also a very important part of the multidimensional intervention in CR,
94
 particularly in 
very elderly and frail or sarcopenic/cachectic patients, where a poor nutritional status is one of the 
main pathophysiologic mechanism for frailty. Recent studies suggest that improving nutritional 
status may reduce the risk of frailty.
95,96
 Furthermore, a recent review has shown that nutrition 
may improve the functional outcome of elderly and frail patients.
97
 
 
Future directions  
 
Step 1: Feasibility of frailty measurement in the setting of cardiac rehabilitation 
Assessment of frailty in the CR requires additional time within routine clinical evaluation. While 
the addition of frailty tools to the management of the elderly patient holds promise, multiple 
topics should be clarified before recommending their widespread clinical application. These 
include identifying which of the many tools provides the best combination of performance and 
facility, with clear definition of standardized values.  
A variety of instruments for measuring frailty could be tested in CR and compared regarding their 
practical feasibility, trying to achieve a compromise between simplicity of administration and 
completeness of frailty domain representation. It is important to stress that the proposed tools 
should be selected among those already validated in hospitalized patients with cardiovascular 
disease, and particularly in patients after an acute coronary event or with CHF, who are likely to be 
similar to those admitted to CR programs. It is uncertain whether tools validated before the index 
event for CR or in other clinical setting may be applicable to patients after a cardiovascular acute 
event/intervention. 
The EFS could be used as representative of a user friendly but comprehensive instrument (see also 
Table 3).
23
 The EFS is easy to administer, requiring <5 min to be performed; it can be administered 
by any professional (nurse, technician) or student; and it has been validated in elderly patients 
after acute coronary syndromes,
49
 where it was found to correlate with prognosis. It includes also 
2 clinical performance items interrogating cognition (clock test) and functional performance 
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(Timed up and go-TUG-test). Despite that  tools based on the deficit accumulation model, such as 
the 40 item FI adopted by Singh et al.
98
 , adopted in elderly patients in acute geriatric 
rehabilitation wards, could be used to assess prognosis or guide intervention planning, or for 
evaluating frailty changes with time, in the busy Cardiac Rehabilitation word, tools based on deficit 
accumulation model may be cumbersome to be applied. Therefore, a more simple and handy tool 
based on a standardized subjective evaluation of frailty  would be more easily accepted and 
adopted, such as the Canadian Study on Health and Ageing Clinical Frailty Scale
22
 (Table 3) 
These authors, through the EACPR, seek to evaluate the feasibility of applying these tools in CR 
centers through a European Registry study in all elderly patients over 75 years old. This would 
have the advantage of familiarizing the cardiologist working in CR with frailty instruments, whilst 
screening for the frequency of frail elderly patients enrolled in European cardiac rehabilitation 
centers.  
Some practical points should be discussed, such as who carries out these measurements. It is the 
authors ? opinion that, due to the simple nature of the data to be collected, any health professional 
(cardiologist, cardiologist in training, nurse, AHP or medical student) could perform a FI 
measurement, provided a uniform method of data collection is agreed and shared within and 
between CR centers 
The timing of frailty assessment in CR is also relevant. It is the ĂƵƚŚŽƌƐ ? opinion that frailty should 
be measured at admission to CR if the patient is already stable, or later as soon as clinical stability 
is reached in the course of the rehabilitative program. We believe that this approach is more 
correct, since before the acute event or surgery a frailty status may be worsened by the severity of 
disease, and may improve after clinical stabilization is reached in CR... On the other side,  in 
patients entering CR after cardiac surgery, surgical complications in addition to  a pre-surgical 
disability may  limit their function, and it would be wise to wait for a progressive improvement in 
physical function before screening patients for frailty.  
 
Step 2. Frailty and prognosis 
It is still uncertain whether the addition of any frailty score/index to routine assessments in elderly 
patients entering CR may increase the prognostic capacity of that setting.  
Therefore, these instruments should be tested in the CR environment as prognostic indicators 
against clearly defined end points, such as hospitalization length, functional capacity, quality of 
13 
 
life, disability, and compared to traditional prognostic indicators. In this regard, a prospective 
observational study could be proposed for CR centers in Europe to evaluate the prognostic ability 
of frailty tools. If this is successful, CR practitioners may acquire an added tool to improve the 
prediction of outcomes, and be able to better tailor the type and intensity of interventions for frail 
patients.  
In conclusion, it is the opinion of these authors that lead CR practitioners should work together 
with Geriatricians to become more familiar with frailty instruments and their application in the 
clinical environment in very elderly patients, to improve their prognostic ability and to design 
specific tailored interventions in complex patients. Further large studies can then be undertaken, 
to determine if the use of frailty measurement improves outcomes for elderly and frail patients 
admitted to CR. 
 
Key messages 
x Frailty is a condition specifically present in the elderly population, characterized by declining 
function of multiple physiologic systems associated with loss of physiologic reserves  
x Two main models are proposed for frailty: phenotypic model (primary frailty) or deficits 
accumulation model (secondary frailty) 
x Different instruments have been used to measure frailty  
x Frailty correlates to medical outcomes in the elderly, independently of how it is measured 
x Frailty has been shown to have prognostic value for patients with: coronary artery disease, 
cardiac surgery, TAVR, CHF and LVAD  
x The prevalence, clinical and prognostic relevance of frailty in a CR environment has not yet 
been well characterized 
x The presence and severity of frailty may  modulate the  CR program by and design tailored 
interventions  
x We need to better understand to what extent CR may change the course and the prognosis of 
frailty, especially in cardiovascular patients, since exercise training and nutrition are well-known 
cornerstones in the management of elderly cardiac patients. 
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Recommended tools for frailty evaluation in CR 
Tool Items  Reference 
Edmonton frail scale 17 simple questions or tasks, assessing cognition, self-
perceived health, dependence for ADL, social support, 
medication use, nutrition, mood, continence and 
functional performance. 
Each item is given from 0 to 2 points, and a frailty state is 
assigned to a global scores > 8/17  
23 
Clinical Frailty scale 
from the CSHA study 
Frailty assessment tool in the domains of mobility, 
energy, physical activity, and function. 
Scale ranging from a level of 1 (very fit) to 8 (very 
severely frail)  
22 
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